Haibing Zhou

25PUBLICATIONS

29CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Medical devicesCharacterisation of biological macromoleculesMolecular targetsPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (25)

Sort by Publication Date:

|Jul 07, 2026

Discovery of Effective Dual PROTAC Degraders with Synergistic Antitumor Activity for Overcoming Tamoxifen-Resistant Breast Cancer.

|May 26, 2026

Hydrophobic Tag Degraders Overcome Endocrine-Resistant Breast Cancer by Recruiting HSP27-Mediated E3 Ligase Complex for ERα Proteasomal Degradation.

|Apr 08, 2026

Identification of Novel Amino Acid-based PROTACs Exhibiting Broad-Spectrum Antiviral Activity Against Enteroviruses.

Tianai Fan, Maoze Yang, Yumeng Cai

|Nov 11, 2025

Kill Two Birds with One Stone: An Efficient and Potent AR CBS-Targeted Degrader Reverses Breast Cancer Resistance via Concurrent AR Degradation and ERα Transcriptional Suppression.

Yihe Wu, Baohua Xie, Jinsen Liang

|Jun 18, 2025

Discovery of ERα-targeting PROTACs with intrinsic fluorescence for precision theranostics of breast cancer.

Yihe Wu, Junhong Dai, Xiaofei Deng

|Jun 17, 2025

Targeted Degradation of the Estrogen Receptor α through Unconventional Coactivator Binding Site (CBS).

Yubo Wang, Baohua Xie, Xiaofei Deng

Pageof 5

Frequent Collaborators

Chune Dong

Yongshi Yu

Lilan Xin

Chang Min

Xiwang Li

Xiaodong Shi

Min Qiu

Zhinang Yin

Guo-Jun Zhang

Lingyu Lei

Frequent Collaborators

Chune Dong

Yongshi Yu

Lilan Xin

Chang Min